[1] 刘 刚,李晓燕.喹唑啉酮类化合物合成新方法研究进展[J].药学进展, 2007,31(12): 542-550.
[2] 佟茂国.喹唑啉类化合物的合成及其抗肿瘤活性研究进展[J].广州化工,2012,40(3),17-19.
[3] Chandrika P M,Yakaiah T,Gayatri G,et al.Click chemistry: studies on the synthesis of novel fluorous tagged triazol -4 -yl substituted quinazoline derivatives and their biological evaluation-theoretical and experimental validation[J].Eur J Med Chem,2010,45: 78-84.
[4] El-Gazzar ABA,Youssef MM,Youssef AM S,et al.Design and synthesis of azolopyrimidoquinolines,pyrimidoquinazolines as anti-oxidant,anti-inflammatory and analgesic activities[J].Eur J Med Chem,2009,44: 609-624.
[5] 李文举,欧阳贵平,张广龙.4-取代氨基喹唑啉类化合物的研究进展[J].精细化工中间体,2009,39(3),15-20.
[6] Lee JY,Park YK,Seo SH,et al.1,4-dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase[J]. Arch Pharm Res,2001, 334(11):357-360.
[7] Lee JY,Lee YS,Park HK, et al.4-(Phenylamino)[1,4] dioxano[2,3-g] quinazoline derivatives and process for preparing the same: USA,2003045537[P]. 2003-03-06.
[8] 宁微微,刘雪飞,张晓梦,等.新型喹唑啉酮类先导物的设计、合成及抑制人顶体酶活性研究[J].药学实践杂志,2010,28(4),296-298,312.
[9] Ioannis K,Abdelhakim E,Elisabeth S,et al.Rapid synthesis of 2,3-disubstituted-quinazolin-4-ones enhanced by microwave-assisted decomposition of formamide [J]. Tetrahedron Lett,2007, 48: 6609.
[10] 宋桂红,张 珏,张晓梦,等.南德士抑制人精子顶体酶活性的实验研究[J].中华男科学杂志, 2009, 15(8): 700.
[11] 付丙月,唐 辉,郑灿辉,等.四氢萘类化合物合成工艺研究[J].药学实践杂志,2012,30(1),35-37.
[12] NCCLS.Reference method for broth dilution antifungal susceptibility testing of yeasts;approved standard[S].2nd ed.Villanova:[s.n.],2000.
[13] 曹永兵,姜远英,王 宁,等.微量液基稀释法测定化合物特苄康唑的体外抗真菌活性[J].中国抗生素杂志, 2000, 25, 183.